Intracardiac thrombus and Murphy's law: Reflections on a clinical dilemma

Patrícia Rodrigues1, Maria João Sousa1, Luísa Caiado1

  • 1Cardiology Department, Centro Hospitalar do Porto, Porto, Portugal.

Insights

A patient with left ventricular systolic dysfunction experienced systemic embolization despite anticoagulation for apical thrombus. This case highlights the need for tailored treatment strategies for intracardiac thrombus with high embolic risk.

Area of Science:

  • Cardiology
  • Cardiovascular Medicine
  • Thrombosis Research

Background:

  • Left ventricular systolic dysfunction (LVSD) is a significant cardiovascular condition.
  • Intracardiac thrombus formation, particularly apical thrombus, is a known complication of LVSD.
  • Systemic embolization from intracardiac thrombus poses a severe risk of morbidity and mortality.

Observation:

  • A 49-year-old patient with LVSD presented with a large, mobile, and protruding apical thrombus.
  • Despite receiving anticoagulation therapy, the patient experienced extensive and clearly defined systemic embolization.
  • The clinical course underscored the limitations of standard anticoagulation in preventing embolization in high-risk cases.

Findings:

  • The case demonstrates a challenging clinical scenario where anticoagulation alone was insufficient to prevent systemic embolization from a high-risk apical thrombus.
  • Evidence regarding the optimal management of intracardiac thrombi with significant embolic potential is reviewed.
  • A tailored therapeutic approach is proposed to mitigate the risk of catastrophic embolic events.

Implications:

  • This case emphasizes the critical need for individualized treatment strategies for patients with intracardiac thrombus and high embolic risk.
  • Early consideration of alternative or adjunctive therapies beyond anticoagulation may be warranted.
  • Improved management protocols could potentially reduce the incidence of severe embolic complications in cardiovascular patients.

Related Concept Videos

Venous Thrombosis I: Introduction01:30

Venous Thrombosis I: Introduction

Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
666
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care01:29

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
638
Myocarditis II: Clinical Features and Diagnostic Tests01:27

Myocarditis II: Clinical Features and Diagnostic Tests

Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
438
Pulmonary Embolism I: Introduction01:29

Pulmonary Embolism I: Introduction

Pulmonary embolism (PE) occurs when a thrombus, fat or air embolus, amniotic fluid, or tumor tissue blocks one or more pulmonary arteries. These blockages originate in the venous system or the right side of the heart.EtiologyPE primarily arises from deep vein thrombosis (DVT) and other hypercoagulable states, such as inherited thrombophilias. Additional etiological factors include venous stasis, commonly seen in obesity, and endothelial injury from surgery and trauma. Less common causes include...
1.2K
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies01:20

Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies

The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...
432
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
687